US929610A - Commercial package of medicine. - Google Patents

Commercial package of medicine. Download PDF

Info

Publication number
US929610A
US929610A US399890A US1907399890A US929610A US 929610 A US929610 A US 929610A US 399890 A US399890 A US 399890A US 1907399890 A US1907399890 A US 1907399890A US 929610 A US929610 A US 929610A
Authority
US
United States
Prior art keywords
medicine
oil
package
film
bottle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US399890A
Inventor
Josiah K Lilly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US33302606A external-priority patent/US876366A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to US399890A priority Critical patent/US929610A/en
Application granted granted Critical
Publication of US929610A publication Critical patent/US929610A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/18Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient
    • B65D81/22Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents providing specific environment for contents, e.g. temperature above or below ambient in moist conditions or immersed in liquids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00Special receptacle or package
    • Y10S206/828Medicinal content

Definitions

  • liquid pharmaceutical preparation consisting broadly of a ferrous salt, a carbonate, or its equivalent, and a liquid carrier for these two substances of such character as to prevent their combination into ferrous carbonate,
  • my imprir-ed pharmaceutical pre )aration comprises specifically a mixture of ferroussulfate, potassium carbonate and glycerin, although of course it will be understood that any satisfactory ferrous salt may be substituted for the sulfate, any satisfactory alkaline carbonate, or other substance capable of furnishing the necessary CO group for the subsequent production of ferrous carbonate, may be substituted for the potassium carbonate, and any liquid carrier capable of holding the other ingredients in suspension so as to prevent the normal production of ferrous carbonate may be substituted for the glzycerin.
  • any desirable form of package may be used but the ordinary bottle, such as is illustrated in the drawings, is probably the most satisfactory. scribed is delivered into the bottle so as to nearly fill the same and I add to this mixture at small quantity of a neutral non-volatile oil, conveniently a tasteless and colorless petroleum oil, in sufficient quantity to form a light film entirely over the top of the li uid'.
  • a neutral non-volatile oil conveniently a tasteless and colorless petroleum oil
  • the carbon dioxid gas remains in the bottle so long as the package is continued in its original condition, but of course disappears as soon as the bottle is uneorked and the first dose of medicine is taken.
  • a dose of the medicine is only a small portion of the contents of the bottle and instructions are therefore given to shake Well before taking so that the film of protecting oil will be broken up and distributed in the body of the medicme.
  • a dose is poured off under these conditions only a very small part of the 'oil passes out and as soon as the bottle is alowed to remain standing for a short time the oil gathers at the top of the medicine and again forms a protecting film which is substantially air and moisture tight, and therefore prevents the access of air and moisture to the medicine.
  • a package of medicine comprising a vessel containlng a liquid medicine, a thin film of oil upon such medicine, a stop er, and a volume of carbon dioxid gas filling the space between the stopper and oil film.
  • a package of medicine comprising a vessel containing a liquid medicine, a thin In witness whereof, I have hereunto set my hand and seal at Indiana )olis, Indiana, this twenty-sixth day of ()cto lxn', A. I). one 20 thousand nine hundred and seven.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Description

J. K. LILLY. COMMERCIAL PACKAGE OF MEDICINE.
APPLICATION FILED 001230, 1907. Patented July 27, 1909.
witnesses )ZM/ifl UNITED STATES PATENT OFFICE.
' JOSIAH K. LILLY, OF INDIANAPOLIS, INDIANA, A'SSIGNOR TO ELI LILLY & COMPANY, OF INDIANAPOLIS, INDIANA, A CORPORATION OF INDIANA.
. CoMMEnCIAL PACKAGE OF MEDICINE.
Specification of Letters Patent.
' Patented July 27, 1909.
Original application tiled September 1, 1906, Serial No. 333,026. Divided and this application filed October 30, 1907. Serial No. 899,890.
To all whom it may concern:
Be it known that I, JosIAII Ix. LILLY, a citizen of" the United States, residing at In dianapolis, in the county of Marion and State v of Indiana, have invented certain new and useful Improvements in Commercial Packages of a Pharmaceutical Preparation, of which the following is a specification.
In the nt-anufacture and marketing of a liquid pharmaceutical preparation consisting broadly of a ferrous salt, a carbonate, or its equivalent, and a liquid carrier for these two substances of such character as to prevent their combination into ferrous carbonate,
and prevent their oxidation, and consisting specifically of a solution of ferrous sulfate and sodium carbonate in glycerin, it has been found that, in order that the preparation may retain its medicinal value for a long period, it is desirable to so package the preparation as to protect it while sealed and auto m atically protect it after it has been once unsealed. My present application, therefore,
. which is a division of my application Serial No. 333,026, filed September 1,1906, relates to the improved package for this pharmacew tical preparation.-
The accompanying drawing is a vertical section of a package embodying my invention;
As disclosed in the application before mentioned, my imprir-ed pharmaceutical pre )aration comprises specifically a mixture of ferroussulfate, potassium carbonate and glycerin, although of course it will be understood that any satisfactory ferrous salt may be substituted for the sulfate, any satisfactory alkaline carbonate, or other substance capable of furnishing the necessary CO group for the subsequent production of ferrous carbonate, may be substituted for the potassium carbonate, and any liquid carrier capable of holding the other ingredients in suspension so as to prevent the normal production of ferrous carbonate may be substituted for the glzycerin.
In ractice I have found that, for producg tfie medicine in commercial quantities, the following formula has been satisfactory. (a) In elevenv (11) gallons of pure glycerin dissolve, by aid of gentle heat, three (3) pounds, four (4) ounces, two hundred and rinety-two (292) grains of pure ferrous sulfate. (b) In four (4) gallons of pure glycerin dissolve, by aid of gentle heat,'one (1) pound,
ten (10) ounces, ninety (90) grains of pure potassium carbonate. (c) \Vhen cool, place solution (a) in an earthenware vessel. of sufficient capacity and add slowly, with stirring, solution (1)). When thoroughly mixed, pour on sufficient pure mineral'oil to cover the surface in order to protect from oxygen and moisture in the air, whereupon it is ready to be drawn off from below into bottles or other suitable packages. 7
Any desirable form of package may be used but the ordinary bottle, such as is illustrated in the drawings, is probably the most satisfactory. scribed is delivered into the bottle so as to nearly fill the same and I add to this mixture at small quantity of a neutral non-volatile oil, conveniently a tasteless and colorless petroleum oil, in sufficient quantity to form a light film entirely over the top of the li uid'.
Then, in order to further prevent any 5 ightreaction which might result from airv in the u )per end of the bottle during a long period ofstorage, either in thefactory or on a druggists shelves, I fill the space in the bottle, above the oil film, with carbon dioxid gas and then seal tightly by a cork or otherwise, as clearly indicated in the, drawing. The oil which is used as a film should preferably be tasteless and colorless, and the quantity relative to the medicine is quite small.
The carbon dioxid gas remains in the bottle so long as the package is continued in its original condition, but of course disappears as soon as the bottle is uneorked and the first dose of medicine is taken. A dose of the medicine is only a small portion of the contents of the bottle and instructions are therefore given to shake Well before taking so that the film of protecting oil will be broken up and distributed in the body of the medicme. When a dose is poured off under these conditions only a very small part of the 'oil passes out and as soon as the bottle is alowed to remain standing for a short time the oil gathers at the top of the medicine and again forms a protecting film which is substantially air and moisture tight, and therefore prevents the access of air and moisture to the medicine.
In the presenceof water the ferrous sul- The mixture hereinbefore de- 4 'fate and the potassium carbonate readily unite to form. the medicinal ferrous-carbonate and as 011 is desirable to serveas a protection against lycerin is hygroscopic the film of.
the absorption of water by the glycerin. film of non-volatile petroleum oil upon such This protection will continue so long as there i medicine, a stopper, and a volume of carbon 15 Is any medicine left in the package, the oil dioxid gas filling the space between the stopbeing sufiicient in quantity to continue to per and oil film.
form a thin film even for the last dose.
I claim as my invention:
1. A package of medicine comprising a vessel containlng a liquid medicine, a thin film of oil upon such medicine, a stop er, and a volume of carbon dioxid gas filling the space between the stopper and oil film.
2. A package of medicine comprising a vessel containing a liquid medicine, a thin In witness whereof, I have hereunto set my hand and seal at Indiana )olis, Indiana, this twenty-sixth day of ()cto lxn', A. I). one 20 thousand nine hundred and seven.
JOSIAH 1i. LILLY.
Witnesses:
ARTHUR M. H001), THOMAS W. McM EANS.
US399890A 1906-09-01 1907-10-30 Commercial package of medicine. Expired - Lifetime US929610A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US399890A US929610A (en) 1906-09-01 1907-10-30 Commercial package of medicine.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33302606A US876366A (en) 1906-09-01 1906-09-01 Composition for the production of ferrous carbonate.
US399890A US929610A (en) 1906-09-01 1907-10-30 Commercial package of medicine.

Publications (1)

Publication Number Publication Date
US929610A true US929610A (en) 1909-07-27

Family

ID=2998034

Family Applications (1)

Application Number Title Priority Date Filing Date
US399890A Expired - Lifetime US929610A (en) 1906-09-01 1907-10-30 Commercial package of medicine.

Country Status (1)

Country Link
US (1) US929610A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2803583A (en) * 1952-10-16 1957-08-20 Novo Terapeutisk Labor As Aqueous suspensions of penicillin compounds exhibiting decreased caking on storage and maintained resuspendability
US4228893A (en) * 1979-04-02 1980-10-21 Ppg Industries, Inc. Inhibition of paint-product skin formation on the interior surface of a paint vessel lid
US4867312A (en) * 1988-10-17 1989-09-19 Norton Company Container sealing means for air and moisture sensitive materials
US5230427A (en) * 1991-06-12 1993-07-27 Ppg Industries, Inc. Sterilizable hermetically-sealed substantially glass container

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2803583A (en) * 1952-10-16 1957-08-20 Novo Terapeutisk Labor As Aqueous suspensions of penicillin compounds exhibiting decreased caking on storage and maintained resuspendability
US4228893A (en) * 1979-04-02 1980-10-21 Ppg Industries, Inc. Inhibition of paint-product skin formation on the interior surface of a paint vessel lid
US4867312A (en) * 1988-10-17 1989-09-19 Norton Company Container sealing means for air and moisture sensitive materials
US5230427A (en) * 1991-06-12 1993-07-27 Ppg Industries, Inc. Sterilizable hermetically-sealed substantially glass container

Similar Documents

Publication Publication Date Title
GB859434A (en) Improved multi-compartment package
DE3367895D1 (en) Valve for the escape of vapour from a container
US929610A (en) Commercial package of medicine.
US1408757A (en) Transportation of hydrocyanic acid
ES8203602A1 (en) Process for filling hard capsules with pharmaceutical products containing phospholipids and being highly viscous at room temperature.
US3159546A (en) Capsule sealing composition
GB873706A (en) Improvements in or relating to cartons and like containers
US1074747A (en) Process and apparatus for sealing carbon tetrachlorid.
EP0540288B1 (en) Toothpaste composition
FR2283064A1 (en) Container for separate materials - with liq. in main body and solid sealed of by rupturable membrane
US1523580A (en) Solidified fuel
US2018570A (en) Method and means for treating motor fuels
US1570418A (en) Preserved yeast and process of making it
US64251A (en) Henry pembebton
Blaug et al. A study of moisture vapor transmission through closures
US2219416A (en) Compound for treating water in boilers
US2546179A (en) Process of handling sugar
US3537898A (en) Method for unclogging conduits
JPS63307060A (en) Plug of container for liquid agent
US169595A (en) Improvement in egg-preserving compounds
GB191412531A (en) Discharge Valve.
JPS59174473A (en) Moistureproof packing method of aerosol agent
GB187840A (en) Improvements relating to machines for packing powdered and like materials
DE806786C (en) Process for storing and transporting low-boiling liquefied gases
GB456996A (en) Improvements in the softening of water and prevention of scale